Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 9471-9480 of 11953

Edit search filters
  1. AI-Driven, FDG-PET Based Approach to Track Disease Progression and Evolution to Phenoconversion in Progranulin Mutation Carriers

    Rochester, MN

  2. Urinary Urate Levels in Patients With ADPKD

    Jacksonville, FL

  3. Assessing the Role of Telemedicine for Forensic Certification Exams

    Rochester, MN

  4. Outcomes Hip and Shoulder Decompression

    Rochester, MN

  5. Assessment of Uncertainty and Its Relationship to Important Transplant Outcomes

    Rochester, MN

  6. Investigating the Feasibility and Clinical Utility of the Marpe Skin Scanner

    Rochester, MN

  7. Le Bonheur Neuroscience Institute Database

    Rochester, MN

  8. Integrated Behavioral Health Techniques in Patients with Fibromyalgia

    Rochester, MN

  9. Use of Ultrasound to Treat Anterior Vein Pain after Total Knee Arthroplasty

    Jacksonville, FL

  10. Evaluating FDG PET-MRI-based Biomarkers In Borderline Resectable Pancreatic Cancer

    Rochester, MN

.

Mayo Clinic Footer